Page 172 - 2023 SMOG Digital
P. 172

PROCAINAMIDE          Lactation?(Not Recommended)   Trade Name: Procanbid
          Class / Mechanism of Action
          Antiarrhythmic Agent, Class Ia
          Decreases myocardial excitability & conduction velocity, may depress myocardial contractility by
          increasing the electrical stimulation threshold of ventricle, His-Purkinje system and through direct cardiac
          effects
          Onset of action: IV: 5min, IM: (Not for emergent situations) 10-30min, Duration 4-6hr
          Indications
          Labeled Indications: Treatment of supraventricular arrhythmias, life-threatening ventricular arrhythmias.
          Unlabeled: Atrial fibrillation (preexcited); Junctional tachycardia; Stable monomorphic ventricular
          tachycardia.
          Contraindications
          •  Hypersensitivity to procainamide, procaine, other ester-type local anesthetics
          •  complete heart block; second-degree AV block or various types of hemiblock
          •  SLE (Systemic lupus erythematosus)
          •  Torsade de pointes
          Adverse Reactions / Precautions
          •  Lupus-like syndrome
          •  Hypotension
          •  Skin rash
          •  Diarrhea, dysgeusia, nausea/vomiting
          Dose and Administration:                ADULT           PEDIATRIC Always Reference BROSELOW Tape
          Ventricular arrhythmias/ Atrial fibrillation   Ventricular arrhythmias:
          (preexcited):                 Infants, Children, and Adolescents IV:
          Note: Dose must be individualized and titrated to   •  Loading dose: 10-15mg/kg over 30-60min
          patient response                     Neonates: Administer over 60min
          •  IV Loading dose: 10-17mg/kg at a rate of   o  Infants and Children: Administer over
            20-50mg/min or 100mg q5min;      o  30-60min
          •  Must dilute prior to IV administration. Dilute   Adolescents: Administer at usual
            loading dose to a maximum concentration of   o  infusion rate: 20-50mg/min not to
            20mg/mL; administer loading dose at a max rate   exceed 50mg/min
            of 50mg/min until:
              o  Arrhythmia suppression  •  Maintenance infusion: 20-80mcg/kg/min;
                                           maximum daily dose: 2000mg/24hr
              o  Hypotension
              o  QRS widens by >50%
              o  total dose 17mg/kg reached  Note: Infusion rate should be decreased if QT
                                        interval becomes prolonged or patient develops
                                        heart block; discontinue the infusion if patient
          •  Maintenance infusion: 2-6mg/min  develops hypotension or QRS interval widens to
                                        >50% of baseline; severe hypotension can occur
                                        with rapid IV administration









        172
   167   168   169   170   171   172   173   174   175   176   177